These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 34105560)
1. Structural variation of protein-ligand complexes of the first bromodomain of BRD4. Guest EE; Pickett SD; Hirst JD Org Biomol Chem; 2021 Jun; 19(25):5632-5641. PubMed ID: 34105560 [TBL] [Abstract][Full Text] [Related]
2. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1. Tumdam R; Kumar A; Subbarao N; Balaji BS SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639 [TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650 [TBL] [Abstract][Full Text] [Related]
4. Pyronaridine as a Bromodomain-Containing Protein 4- Ibrahim MAA; Abdelhamid MMH; Abdeljawaad KAA; Abdelrahman AHM; Mekhemer GAH; Sidhom PA; Sayed SRM; Paré PW; Hegazy MF; Shoeib T Molecules; 2023 Jul; 28(15):. PubMed ID: 37570684 [TBL] [Abstract][Full Text] [Related]
5. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach. Shanmugam V; Muthukrishnan S J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551 [TBL] [Abstract][Full Text] [Related]
6. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Liu Z; Li Y; Chen H; Lai HT; Wang P; Wu SY; Wold EA; Leonard PG; Joseph S; Hu H; Chiang CM; Brasier AR; Tian B; Zhou J J Med Chem; 2022 Feb; 65(3):2388-2408. PubMed ID: 34982556 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations. Tong JB; Xiao XC; Luo D; Xu HY; Xing YC; Gao P; Liu Y Mol Divers; 2024 Apr; 28(2):671-692. PubMed ID: 36773087 [TBL] [Abstract][Full Text] [Related]
8. Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis. Gupta A; Purohit R J Cell Biochem; 2024 Mar; 125(3):e30532. PubMed ID: 38317535 [TBL] [Abstract][Full Text] [Related]
9. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors. Raj U; Kumar H; Varadwaj PK J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802 [TBL] [Abstract][Full Text] [Related]
10. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639 [TBL] [Abstract][Full Text] [Related]
11. The binding mechanism of NHWD-870 to bromodomain-containing protein 4 based on molecular dynamics simulations and free energy calculation. Shi M; He J; Weng T; Shi N; Qi W; Guo Y; Chen T; Chen L; Xu D Phys Chem Chem Phys; 2022 Feb; 24(8):5125-5137. PubMed ID: 35156677 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor. Hagihara S; Ishizawa K; Soga K; Honjo T; Takai S; Kawano Y; Kikuchi M; Nishidate A; Matsumoto F; Murase M; Hashimoto N; Sasaki C; Miyaguchi I; Okada O; Akashi T; Nakayama S; Ogasawara Y; Endo J Bioorg Med Chem Lett; 2024 Sep; 109():129849. PubMed ID: 38876177 [TBL] [Abstract][Full Text] [Related]
13. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites. Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490 [TBL] [Abstract][Full Text] [Related]
14. Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4. Wang Q; Li Y; Xu J; Wang Y; Shi D; Liu L; Leung EL; Yao X Proteins; 2019 Jan; 87(1):3-11. PubMed ID: 30260047 [TBL] [Abstract][Full Text] [Related]
15. In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4. Rodríguez Y; Gerona-Navarro G; Osman R; Zhou MM Proteins; 2020 Mar; 88(3):414-430. PubMed ID: 31587361 [TBL] [Abstract][Full Text] [Related]
16. Molecular Dynamic Simulations of Bromodomain and Extra-Terminal Protein 4 Bonded to Potent Inhibitors. Chen S; He Y; Geng Y; Wang Z; Han L; Han W Molecules; 2021 Dec; 27(1):. PubMed ID: 35011350 [TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign. Colarusso E; Gazzillo E; Boccia E; Terracciano S; Bruno I; Bifulco G; Chini MG; Lauro G Molecules; 2024 Aug; 29(17):. PubMed ID: 39274873 [TBL] [Abstract][Full Text] [Related]
18. Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4. Schulze J; Moosmayer D; Weiske J; Fernández-Montalván A; Herbst C; Jung M; Haendler B; Bader B J Biomol Screen; 2015 Feb; 20(2):180-9. PubMed ID: 25266565 [TBL] [Abstract][Full Text] [Related]
19. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning. Wang J; Yang W; Zhao L; Wei B; Chen J Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays. Sun Z; Zhang H; Chen Z; Xie Y; Jiang H; Chen L; Ding H; Zhang Y; Jiang H; Zheng M; Luo C Bioorg Med Chem Lett; 2017 May; 27(9):2003-2009. PubMed ID: 28347667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]